Comparing the Quality of Life in Patients With Multiple Sclerosis Consuming Fingolimod and Cinnovex
Background: Multiple Sclerosis (MS) is a chronic demyelinating, inflammatory, and degenerative disease of the central nervous system. MS gradually limits and deteriorates the patients’ quality of life. Objectives: This study aimed to evaluate and compare the quality of life in patients with MS consu...
Main Authors: | Alia Saberi, Hamidreza Hatamian, Amirreza Ghayeghran, Fatemeh Mola Hosseini, Sama Noroozi Guilandehi, Sajjad Rezaei, Fatemeh Shafaei |
---|---|
Format: | Article |
Language: | English |
Published: |
Guilan University of Medical Sciences
2019-11-01
|
Series: | Caspian Journal of Neurological Sciences |
Subjects: | |
Online Access: | http://cjns.gums.ac.ir/article-1-291-en.html |
Similar Items
-
Effect of fingolimod on platelet count among multiple sclerosis patients
by: Mehrdad Farrokhi, et al.
Published: (2015-01-01) -
Sensory-Neural Hearing Loss as an Early Rebound Relapse after Fingolimod Cessation in Multiple Sclerosis
by: Abdoreza Naser Moghadasi, et al.
Published: (2020-07-01) -
CRITICAL APPRAISAL OF EFFECTIVENESS OF ORAL FINGOLIMOD ON RELAPSING MULTIPLE SCLEROSIS
by: Rizaldy Taslim Pinzon, et al.
Published: (2017-11-01) -
Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study
by: Rozita Doosti, et al.
Published: (2021-04-01) -
Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
by: Burcu Altunrende, et al.
Published: (2017-12-01)